Skip to content

Recurrence of events within 1 year after discharge in patients with atherosclerotic cardiovascular and cerebrovascular diseases in Fujian

Recurrence of events within 1 year after discharge in patients with atherosclerotic cardiovascular and cerebrovascular diseases in Fujian: a real-world prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090377
Enrollment
Unknown
Registered
2024-09-29
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease or cerebral infarction

Interventions

Patients with atherosclerotic cardiovascular and cerebrovascular diseases:NA

Sponsors

the First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-80 years old; (2) Patients diagnosed with coronary heart disease (coronary angiography or CTA report) or ischemic cerebral infarction (transcranial Doppler ultrasonography or CT or MRI report) by imaging; (3) Patients with hypercholesterolemia (higher than the target value defined in the 2023 Chinese Adult Lipid Prevention Guidelines); (4) Receiving atherogenic drugs; (5) Patients with probucol tablets; (6) Sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Complicated with severe liver and renal insufficiency, hematological diseases and malignant tumors (discretion belongs to the investigator); (2) Unwilling to attend or unable to cooperate with the accompanying visitors; (3) Patients who are pregnant, breastfeeding or have pregnancy plans and may be pregnant; (4) Patients who are allergic to statins and probucol tablets, or who have had serious adverse reactions after taking statins or probucol tablets in the past; (5) People with prolonged Q-T interval are taking drugs that prolong Q-T interval; (6) Other situations that the researcher considers unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Recurrence rate of ischemic stroke;Incidence of unstable angina pectoris;Incidence of myocardial infarction;Incidence of unstable angina pectoris;Incidence of myocardial infarction;

Secondary

MeasureTime frame
Incidence of major adverse cardiovascular events;Incidence of revascularization;Readmission incidence;Incidence of major adverse cardiovascular events;Incidence of revascularization;Readmission incidence;

Countries

China

Contacts

Public ContactYihua Shen

Department of gerontology, the First Affiliated Hospital of Fujian Medical University

673107984@qq.com+86 138 6064 2664

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026